Literature DB >> 18782673

Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry.

Dan Ziegler1, Wolfgang Rathmann, Christa Meisinger, Thorsten Dickhaus, Andreas Mielck.   

Abstract

The lowest glycemic threshold for and the risk factors associated with neuropathic pain have not been established. The aim of this study was to determine the prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), normal glucose tolerance (NGT). Subjects aged 25-74 years with diabetes (n=214) and controls matched for age and sex (n=212) from the population-based KORA (Cooperative Health Research in the Region of Augsburg) Myocardial Infarction Registry were assessed for neuropathic pain by the Michigan Neuropathy Screening Instrument using its pain-relevant questions and an examination score cutpoint >2. An oral glucose tolerance test was performed in the controls. Among the controls, 61 (28.8%) had IGT (either isolated or combined with IFG), 70 (33.0%) had isolated IFG, and 81 had NGT. The prevalence of neuropathic pain was 21.0% in the diabetic subjects, 14.8% in those with IGT, 5.7% in those with IFG, and 3.7% in those with NGT (overall p<0.001). In the entire population studied (n=426), age, waist circumference, peripheral arterial disease (PAD), and diabetes were independent factors significantly associated with neuropathic pain, while in the diabetic group it was waist circumference, physical activity, and PAD (all p<0.05). In conclusion, the prevalence of neuropathic pain is relatively high among survivors of myocardial infarction with diabetes and IGT compared to those with isolated IFG and NGT. Associated cardiovascular risk factors including abdominal obesity and low physical activity may constitute targets to prevent neuropathic pain in this population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18782673     DOI: 10.1016/j.ejpain.2008.07.007

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  27 in total

Review 1.  Neuropathy in prediabetes: does the clock start ticking early?

Authors:  Nikolaos Papanas; Aaron I Vinik; Dan Ziegler
Journal:  Nat Rev Endocrinol       Date:  2011-07-12       Impact factor: 43.330

Review 2.  Neurologic complications of diabetes.

Authors:  Gerald A Charnogursky; Nicholas V Emanuele; Mary Ann Emanuele
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

Review 3.  Painful and painless diabetic neuropathy: one disease or two?

Authors:  Vincenza Spallone; Carla Greco
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

Review 4.  Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015.

Authors:  Nikolaos Papanas; Dan Ziegler
Journal:  Rev Diabet Stud       Date:  2015-08-10

Review 5.  Prediabetic neuropathy: does it exist?

Authors:  Nikolaos Papanas; Dan Ziegler
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

6.  Abnormal Fasting Glucose Increases Risk of Unrecognized Myocardial Infarctions in an Elderly Cohort.

Authors:  Richard Brandon Stacey; Janice Zgibor; Paul E Leaverton; Douglas D Schocken; Jennifer A Peregoy; Mary F Lyles; Alain G Bertoni; Gregory L Burke
Journal:  J Am Geriatr Soc       Date:  2018-10-09       Impact factor: 5.562

Review 7.  Interrelationship of Neurogenic Obesity and Chronic Neuropathic Pain in Persons With Spinal Cord Injury.

Authors:  Elizabeth R Felix; David R Gater
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

Review 8.  Prevalence of peripheral neuropathy in pre-diabetes: a systematic review.

Authors:  Varo Kirthi; Anugraha Perumbalath; Emily Brown; Sarah Nevitt; Ioannis N Petropoulos; Jamie Burgess; Rebecca Roylance; Daniel J Cuthbertson; Timothy L Jackson; Rayaz A Malik; Uazman Alam
Journal:  BMJ Open Diabetes Res Care       Date:  2021-05

9.  Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin.

Authors:  Aaron I Vinik; Carolina M Casellini
Journal:  Diabetes Metab Syndr Obes       Date:  2013-02-22       Impact factor: 3.168

Review 10.  Mechanisms and management of diabetic painful distal symmetrical polyneuropathy.

Authors:  Solomon Tesfaye; Andrew J M Boulton; Anthony H Dickenson
Journal:  Diabetes Care       Date:  2013-09       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.